Cargando…

How can Secondary Thromboprophylaxis in High-Risk Pregnant Patients be Improved?

Low-molecular-weight heparin (LMWH) is suggested for thromboprophylaxis in pregnant women with previous venous thromboembolism (VTE). Anyway, there is only limited amount of studies evaluating the effect of LMWH on hemostatic parameters during pregnancy of patients with previous VTE and the need of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stanciakova, Lucia, Dobrotova, Miroslava, Holly, Pavol, Zolkova, Jana, Vadelova, Lubica, Skornova, Ingrid, Ivankova, Jela, Samos, Matej, Bolek, Tomas, Grendar, Marian, Danko, Jan, Kubisz, Peter, Stasko, Jan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2022
Materias:	Original Manuscript
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8894622/ https://www.ncbi.nlm.nih.gov/pubmed/35225706 http://dx.doi.org/10.1177/10760296211070004

Ejemplares similares

How Can Rotational Thromboelastometry as a Point-of-Care Method Be Useful for the Management of Secondary Thromboprophylaxis in High-Risk Pregnant Patients?
por: Stanciakova, Lucia, et al.
Publicado: (2021)

DNA Polymorphisms in Pregnant Women with Sticky Platelet Syndrome
por: Stančiaková, Lucia, et al.
Publicado: (2022)

Does atorvastatin therapy change the anti‐Xa activity in xabans‐treated patients with atrial fibrillation?
por: Škorňová, Ingrid, et al.
Publicado: (2021)

High On-Treatment Platelet Reactivity in Patients Undergoing Complex Percutaneous Coronary Interventions
por: Urban, Lukáš, et al.
Publicado: (2023)

Type 2 Diabetes, Atrial Fibrillation, and Direct Oral Anticoagulation
por: Prídavková, Dana, et al.
Publicado: (2019)

Heterogeneity of Genotype–Phenotype in Congenital Hypofibrinogenemia—A Review of Case Reports Associated with Bleeding and Thrombosis
por: Brunclikova, Monika, et al.
Publicado: (2022)

Viscoelastic Hemostatic Assays and Platelet Function Testing in Patients with Atherosclerotic Vascular Diseases
por: Samoš, Matej, et al.
Publicado: (2021)

Impact of Edoxaban on Thrombin-Dependent Platelet Aggregation
por: Sokol, Juraj, et al.
Publicado: (2020)

Tailored Direct Oral Anticoagulation in Patients with Atrial Fibrillation: The Future of Oral Anticoagulation?
por: Samoš, Matej, et al.
Publicado: (2022)

Multimer Analysis of Von Willebrand Factor in Von Willebrand Disease with a Hydrasys Semi-Automatic Analyzer—Single-Center Experience
por: Skornova, Ingrid, et al.
Publicado: (2021)

COVID-19 and the Response to Antiplatelet Therapy
por: Bolek, Tomáš, et al.
Publicado: (2023)

A Novel Nonsense Mutation in FGB (c.1421G>A; p.Trp474Ter) in the Beta Chain of Fibrinogen Causing Hypofibrinogenemia with Bleeding Phenotype
por: Simurda, Tomas, et al.
Publicado: (2020)

Role of Thromboelastography and Rotational Thromboelastometry in the Management of Cardiovascular Diseases
por: Korpallová, Barbora, et al.
Publicado: (2018)

Congenital Afibrinogenemia and Hypofibrinogenemia: Laboratory and Genetic Testing in Rare Bleeding Disorders with Life-Threatening Clinical Manifestations and Challenging Management
por: Simurda, Tomas, et al.
Publicado: (2021)

Rotational thromboelastometry in patients with type 2 diabetes and mild COVID-19 pneumonia: A pilot prospective study
por: Bolek, Tomáš, et al.
Publicado: (2022)

Resistance on the Latest Oral and Intravenous P2Y12 ADP Receptor Blockers in Patients with Acute Coronary Syndromes: Fact or Myth?
por: Blaško, Peter, et al.
Publicado: (2022)

The Impact of Type 2 Diabetes on the Efficacy of ADP Receptor Blockers in Patients with Acute ST Elevation Myocardial Infarction: A Pilot Prospective Study
por: Samoš, Matej, et al.
Publicado: (2016)

A Functional Assay for the Determination of Heparin-Induced Thrombocytopenia via Flow Cytometry
por: Skornova, Ingrid, et al.
Publicado: (2023)

Monitoring the hemostasis with rotation thromboelastometry in patients with acute STEMI on dual antiplatelet therapy: First experiences
por: Samoš, Matej, et al.
Publicado: (2017)

Impact of Dabigatran Treatment on Rotation Thromboelastometry
por: Sokol, Juraj, et al.
Publicado: (2021)

Fibronectin, Plasminogen Activator Inhibitor Type 1 (PAI-1) And Uterine Artery Doppler Velocimetry as Markers of Preeclampsia
por: Bodova, Kristina Biskupska, et al.
Publicado: (2011)

Identification of Two Novel Fibrinogen Bβ Chain Mutations in Two Slovak Families with Quantitative Fibrinogen Disorders
por: Simurda, Tomas, et al.
Publicado: (2017)

Basic Principles of Rotational Thromboelastometry (ROTEM(®)) and the Role of ROTEM—Guided Fibrinogen Replacement Therapy in the Management of Coagulopathies
por: Drotarova, Miroslava, et al.
Publicado: (2023)

SARS-CoV-2 Infection-Associated Aortic Thrombosis Treated with Oral Factor Xa Inhibition
por: Strýčková, Alena, et al.
Publicado: (2022)

Genetic Variants in the FGB and FGG Genes Mapping in the Beta and Gamma Nodules of the Fibrinogen Molecule in Congenital Quantitative Fibrinogen Disorders Associated with a Thrombotic Phenotype
por: Simurda, Tomas, et al.
Publicado: (2020)

A Longitudinal Study of Thrombosis and Bleeding Outcomes With Thromboprophylaxis in Pregnant Women at Intermediate and High Risk of VTE
por: Schapkaitz, E., et al.
Publicado: (2023)

Successful immune tolerance induction consisting of high-dose factor VIII rich in von Willebrand factor and pulsed intravenous immunoglobulin: a case report
por: Kubisz, Peter, et al.
Publicado: (2012)

Sticky platelets syndrome in a young patient with massive pulmonary embolism
por: Darulová, Stanislava, et al.
Publicado: (2013)

How to Treat Today? Oral and Facial Cancer-Associated Venous Thromboembolism
por: Janíčková, Mária, et al.
Publicado: (2023)

Association of Genetic Variability in Selected Genes in Patients With Deep Vein Thrombosis and Platelet Hyperaggregability
por: Sokol, Juraj, et al.
Publicado: (2018)

First Evidence: TRAP-Induced Platelet Aggregation Is Reduced in Patients Receiving Xabans
por: Nehaj, Frantisek, et al.
Publicado: (2017)

Type 2 Diabetes and ADP Receptor Blocker Therapy
por: Samoš, Matej, et al.
Publicado: (2016)

Anti-Xa Directed Thromboprophylaxis in Critically Ill Patients with Coronavirus Disease 2019
por: Mohamed, Adham, et al.
Publicado: (2022)

Thrombosis in Myeloproliferative Neoplasms: A Single Center Experience of Using Whole Blood Platelet Aggregation Studies for Risk Assessment and Thromboprophylaxis
por: Manoharan, Arumugam, et al.
Publicado: (2022)

Impact of RASSF1A gene methylation on the metastatic axillary nodal status in breast cancer patients
por: Jezkova, Eva, et al.
Publicado: (2017)

Rivaroxaban Versus Enoxaparin for Thromboprophylaxis After major Gynecological Cancer Surgery: The VALERIA Trial: Venous thromboembolism prophylAxis after gynecoLogical pElvic cancer surgery with RIvaroxaban versus enoxAparin (VALERIA trial)
por: Longo de Oliveira, André Luiz Malavasi, et al.
Publicado: (2022)

Thromboprophylaxis in Pregnant Women with COVID-19: An Unsolved Issue
por: Varlas, Valentin Nicolae, et al.
Publicado: (2023)

Predictors of Anxiety, Stress, and Concern of COVID-19 Infection in Older Adults During the First and the Second Waves of the COVID-19 Pandemic in Slovakia
por: Köverová, Miroslava, et al.
Publicado: (2021)

Glycoprotein VI Gene Variants Affect Pregnancy Loss in Patients With Platelet Hyperaggregability
por: Sokol, Juraj, et al.
Publicado: (2018)

Methylation of CADM1 and MAL together with HPV status in cytological cervical specimens serves an important role in the progression of cervical intraepithelial neoplasia
por: Meršaková, Sandra, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_8q04tps4nk8jptv8s27j6cce83